Fudan University
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1905-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.fudan.edu.cn
Potential Predictive Biomarkers in Patients Undergoing First-line Chemotherapy for Metastatic Colorectal Cancer
- Conditions
- Chemotherapy EffectMetastatic Colorectal CancerBiomarker
- Interventions
- First Posted Date
- 2018-05-22
- Last Posted Date
- 2018-05-22
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 264
- Registration Number
- NCT03532711
Rechallenge of Prior Regimen in Third or Later-line Chemotherapy in Metastatic Colorectal Cancer
- Conditions
- Chemotherapy EffectMetastatic Colorectal Cancer
- Interventions
- Drug: the rechallenge regimen
- First Posted Date
- 2018-04-02
- Last Posted Date
- 2023-12-08
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 43
- Registration Number
- NCT03485027
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
A Study of Intraperitoneal Paclitaxel in Combination With SOX Compared With SOX Alone in Gastric Cancer With Malignant Ascites
- Conditions
- Gastric CancerStomach Neoplasms
- Interventions
- First Posted Date
- 2018-03-23
- Last Posted Date
- 2018-03-23
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 215
- Registration Number
- NCT03475615
- Locations
- 🇨🇳
Fudan University Cancer Hospital, Shanghai, China
Detection of MicroRNA-25 in the Diagnosis of Pancreatic Cancer
- Conditions
- Carcinoma, Pancreatic Ductal
- Interventions
- Diagnostic Test: Serum MicroRNA-25 detection
- First Posted Date
- 2018-02-14
- Last Posted Date
- 2018-02-14
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 750
- Registration Number
- NCT03432624
- Locations
- 🇨🇳
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University, Shanghai, Shanghai, China
Apatinib for Advanced Biliary Carcinoma
- First Posted Date
- 2018-02-09
- Last Posted Date
- 2018-02-09
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 55
- Registration Number
- NCT03427242
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
Safety and Efficacy of Statins for Chinese Patients With Dyslipidemia
- First Posted Date
- 2018-02-01
- Last Posted Date
- 2018-02-01
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 10000
- Registration Number
- NCT03418974
- Locations
- 🇨🇳
School of Public Health, Fudan University, Shanghai, Shanghai, China
🇨🇳Heart Center of Peking University People's Hospital, Beijing, Beijing, China
Hypofractionated PBI After BCS for Low-risk Breast Cancer Patients
- Conditions
- Breast Cancer
- Interventions
- Radiation: hypofractionated partial breast irradiation
- First Posted Date
- 2018-01-26
- Last Posted Date
- 2019-02-04
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 50
- Registration Number
- NCT03411174
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
Maintenance Chemotherapy in High-metastatic Risk Nasopharyngeal Carcinoma Patients of N3 Stage
- Conditions
- Nasopharyngeal Carcinoma
- Interventions
- Drug: GemcitabineRadiation: standard chemoradiotherapy
- First Posted Date
- 2018-01-19
- Last Posted Date
- 2019-07-08
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 360
- Registration Number
- NCT03403829
- Locations
- 🇨🇳
Fudan Universtiy Shanghai Cancer Centre, Shanghai, Shanghai, China
The Combination Chemotherapy of SIRIOX as First- or Second-Line Chemotherapy for Pancreatic Cancer
- First Posted Date
- 2018-01-18
- Last Posted Date
- 2021-04-09
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 65
- Registration Number
- NCT03403101
- Locations
- 🇨🇳
Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University, Shanghai, Shanghai, China
🇨🇳Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University; 270 Dong An Road, Shanghai 200032, China, Shanghai, China
Apatinib in the Treatment of Metastatic Colorectal Cancer
- First Posted Date
- 2018-01-18
- Last Posted Date
- 2018-01-18
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 33
- Registration Number
- NCT03403452
- Locations
- 🇨🇳
Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China